whatshot

OKUR   $7.465  -4.42% Market Closed

Onkure Therapeutics Inc
show_chart Advanced Chart of OKUR

Current temperature: 22.02
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 4
Target Price Mean 35
Mean unverified/preliminary 35 / 35
Target Price Low / High 31 / 40
Median / STD DEV 34 / 3.86
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy None
rsi Buy None None
macd None None None
stoch None None None
ma20 None None None
ma50 None None None
ma100 ActivelyBuy ActivelyBuy None
Candlestick PatternDec. 23, 2024 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US68277Q1058
ceo Dr. Nicholas A. Saccomano Ph.D.
Website https://onkuretherapeutics.com
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops biologically validated drivers of cancers medicines in the United States. The company's lead product candidate is the OKI-219, a selective inhibitor of PI3Ka harboring the H1047R mutation for the treatment of solid tumors, including breast cancer that is in Phase 1 clinical trial. OnKure Therapeutics, Inc. is headquartered in Boulder, Colorado.